UNSPSC 85818820: Transfusion of nonautologous factor ix into central artery, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to transfusion of nonautologous factor ix into central artery, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 30260W1

UNSPSC 85818820 Transfusion of nonautologous factor ix into central artery, open approach is a Commodity code that, based on recent state and local contract opportunities, does not reflect the work actually being solicited under this designation. The recent opportunities posted against this code include independent medical evaluation services for public safety pension boards, surgical benefit carve-out programs for municipal employees, occupational medical surveillance for state ferry workers, specialty and emergency medical services for youth in custody, pharmacy benefit management, and temporary health professional staffing — none of which involve factor ix transfusion or the specific clinical procedure the code nominally describes. The mismatch suggests either systematic miscoding in state and local procurement systems or use of this code as a catch-all placeholder for health services procurements that do not map to narrower clinical codes.

The issuing bodies span diverse jurisdictions: the City of Phoenix Retirement Office, the City of Long Beach, the Washington State Department of Transportation, Harris County Juvenile Probation Department, Collier County Board of County Commissioners, and the County of Santa Clara Health System. Geographic activity appears concentrated in the West (Washington, Arizona, California) and South (Texas, Florida), with recent solicitations posted between late July and mid-September 2026 and response dates ranging from late September through early October 2026. Representative recent opportunities include the City of Phoenix's RFP for independent medical evaluation services (RTMRFP26001, due October 16, 2026, $750,000 over five years) and the Washington State Department of Transportation's RFP for occupational medical surveillance services across 14 Washington locations (RFP20260825, due October 9, 2026). Given the absence of factor ix transfusion procurements in the current pipeline, this code shows little decision-relevant activity for vendors in that clinical specialty and warrants reclassification investigation before further pursuit.